Cargando…

Novel Synergistic Anti-Enteroviral Drug Combinations

Background: Enterovirus infections affect people around the world, causing a range of illnesses, from mild fevers to severe, potentially fatal conditions. There are no approved treatments for enterovirus infections. Methods: We have tested our library of broad-spectrum antiviral agents (BSAs) agains...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ianevski, Aleksandr, Zusinaite, Eva, Tenson, Tanel, Oksenych, Valentyn, Wang, Wei, Afset, Jan Egil, Bjørås, Magnar, Kainov, Denis E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505890/ https://www.ncbi.nlm.nih.gov/pubmed/36146673 http://dx.doi.org/10.3390/v14091866

Ejemplares similares

Active Components of Commonly Prescribed Medicines Affect Influenza A Virus–Host Cell Interaction: A Pilot Study
por: Ianevski, Aleksandr, et al.
Publicado: (2021)

Seven classes of antiviral agents
por: Ianevski, Aleksandr, et al.
Publicado: (2022)

DrugVirus.info 2.0: an integrative data portal for broad-spectrum antivirals (BSA) and BSA-containing drug combinations (BCCs)
por: Ianevski, Aleksandr, et al.
Publicado: (2022)

Nafamostat–Interferon-α Combination Suppresses SARS-CoV-2 Infection In Vitro and In Vivo by Cooperatively Targeting Host TMPRSS2
por: Ianevski, Aleksandr, et al.
Publicado: (2021)

A Systems Approach to Study Immuno- and Neuro-Modulatory Properties of Antiviral Agents
por: Zusinaite, Eva, et al.
Publicado: (2018)

Mono- and combinational drug therapies for global viral pandemic preparedness
por: Ianevski, Aleksandr, et al.
Publicado: (2022)

Potential Antiviral Options against SARS-CoV-2 Infection
por: Ianevski, Aleksandr, et al.
Publicado: (2020)

Discovery and development of safe-in-man broad-spectrum antiviral agents
por: Andersen, Petter I., et al.
Publicado: (2020)

Identification and Tracking of Antiviral Drug Combinations
por: Ianevski, Aleksandr, et al.
Publicado: (2020)

Synergistic Interferon-Alpha-Based Combinations for Treatment of SARS-CoV-2 and Other Viral Infections
por: Ianevski, Aleksandr, et al.
Publicado: (2021)

Broad-Spectrum Antivirals and Antiviral Drug Combinations
por: Oksenych, Valentyn, et al.
Publicado: (2022)

Novel Antiviral Activities of Obatoclax, Emetine, Niclosamide, Brequinar, and Homoharringtonine
por: Andersen, Petter I., et al.
Publicado: (2019)

Broad-Spectrum Antivirals and Antiviral Combinations: An Editorial Update
por: Kainov, Denis, et al.
Publicado: (2022)

Common Nodes of Virus–Host Interaction Revealed Through an Integrated Network Analysis
por: Bösl, Korbinian, et al.
Publicado: (2019)

Low Temperature and Low UV Indexes Correlated with Peaks of Influenza Virus Activity in Northern Europe during 2010–2018
por: Ianevski, Aleksandr, et al.
Publicado: (2019)

DNA Damage Response
por: Oksenych, Valentyn, et al.
Publicado: (2021)

Metformin Therapy Changes Gut Microbiota Alpha-Diversity in COVID-19 Patients with Type 2 Diabetes: The Role of SARS-CoV-2 Variants and Antibiotic Treatment
por: Petakh, Pavlo, et al.
Publicado: (2023)

Novel activities of safe-in-human broad-spectrum antiviral agents
por: Ianevski, Aleksandr, et al.
Publicado: (2018)

Chemical, Physical and Biological Triggers of Evolutionary Conserved Bcl-xL-Mediated Apoptosis
por: Ianevski, Aleksandr, et al.
Publicado: (2020)

Antiviral Immunoglobulins of Chicken Egg Yolk for Potential Prevention of SARS-CoV-2 Infection
por: Ravlo, Erlend, et al.
Publicado: (2022)

Therapeutic Effectiveness of Interferon-α2b against COVID-19 with Community-Acquired Pneumonia: The Ukrainian Experience
por: Kamyshnyi, Aleksandr, et al.
Publicado: (2023)

Influenza Virus Infection, Interferon Response, Viral Counter-Response, and Apoptosis
por: Shim, Jung Min, et al.
Publicado: (2017)

Enteroviral Infections in Infants
por: Singh, Srijan, et al.
Publicado: (2022)

Normal development of mice lacking PAXX, the paralogue of XRCC4 and XLF
por: Gago‐Fuentes, Raquel, et al.
Publicado: (2018)

Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19
por: Ko, Meehyun, et al.
Publicado: (2021)

Altered Blood Molecular Markers of Cardiovascular Function in Rats after Intrauterine Hypoxia and Drug Therapy
por: Popazova, Olena, et al.
Publicado: (2023)

Single Passage of Human Metapneumovirus in LLC-MK2 Cells Does Not Affect Viral Protein-Coding Capacity
por: Loevenich, Simon, et al.
Publicado: (2018)

Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses
por: White, Judith M., et al.
Publicado: (2021)

The F/B ratio as a biomarker for inflammation in COVID-19 and T2D: Impact of metformin
por: Petakh, Pavlo, et al.
Publicado: (2023)

Weil’s Disease—Immunopathogenesis, Multiple Organ Failure, and Potential Role of Gut Microbiota
por: Petakh, Pavlo, et al.
Publicado: (2022)

Association of Myocardial Changes and Gene Expression of the NFATC1 and NFATC4—Calcineurin Signaling Pathway in Children with Bicuspid Aortic Valve
por: Kamenshchyk, Andrii, et al.
Publicado: (2023)

Enterovirus infection in Korean children and anti-enteroviral potential candidate agents
por: Park, Kwi Sung, et al.
Publicado: (2012)

DNA Repair and Immune Response: Editorial
por: Oksenych, Valentyn
Publicado: (2022)

Editorial: Plasticity of immune cells in tumor microenvironment
por: Oksenych, Valentyn
Publicado: (2023)

Disseminated Enteroviral Infection Associated with Obinutuzumab
por: Dendle, Claire, et al.
Publicado: (2015)

The role of microRNAs in enteroviral infections
por: Wu, Jing, et al.
Publicado: (2015)

Computational Drug Repositioning and Experimental Validation of Ivermectin in Treatment of Gastric Cancer
por: Rabben, Hanne-Line, et al.
Publicado: (2021)

SynergyFinder 2.0: visual analytics of multi-drug combination synergies
por: Ianevski, Aleksandr, et al.
Publicado: (2020)

Tyrosine Kinase Inhibitors Target B Lymphocytes
por: Upfold, Nikki Lyn Esnardo, et al.
Publicado: (2023)

The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence
por: Buchynskyi, Mykhailo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sbvluboppdutl34i3l8e4cf606